Target intelligence / Profile preview

NOVA1 divergent transcript (NOVA1-DT)

Target
NOVA1-DT
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Divergent transcript
01

Overview

NOVA1 divergent transcript (NOVA1-DT) is a long intergenic non-coding RNA (lincRNA) located near the protein-coding gene NOVA1. As a member of the lincRNA and lncRNA family, NOVA1-DT does not code for a protein but is thought to be involved in the fine-tuning of gene expression and regulatory processes, potentially affecting transcription, RNA stabilization, and chromatin architecture. Divergent transcripts such as NOVA1-DT are defined by their proximity and opposite orientation relative to protein-coding genes (within 300–500 nucleotides), which may allow regulatory interplay. There is currently no reported role as a therapeutic target, no known drug interactions, and it has not been established as a biomarker or a source of unique safety concerns. While lncRNAs as a group are increasingly recognized for their roles in neurological and transcriptional control, the specific functions and clinical implications of NOVA1-DT require further elucidation.

Other names
C14orf22LINC02588NOVA1-AS1NOVA1 antisense RNA 1 (head to head)NOVA1 antisense RNA 1 (non-protein coding)long intergenic non-protein coding RNA 2588NOVA1-DT
02

Biological functions

Regulation of gene expressionChromatin and genome architecture modulationRNA stabilizationTranscriptional regulationPotential enhancer-associated activity
03

Disease associations

Other (while lncRNAs as a class are implicated in neurological function and diseases, no direct evidence links NOVA1-DT to a specific disease in the current search results)

Beyond the preview

Go deeper on NOVA1 divergent transcript (NOVA1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOVA1 divergent transcript (NOVA1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call